HCPCS code A4560: neuromuscular electrical stimulator, disposable, replacement only

Key Takeaways

HCPCS code A4560 describes a disposable neuromuscular electrical stimulator (NMES), replacement only – it covers replacing the disposable stimulator device itself, not ongoing electrodes, lead wires, or gel used with a durable NMES unit.

Many Medicare DME MACs treat disposable NMES stimulators billed under A4560 as not meeting the regulatory definition of durable medical equipment, and several commercial payers – including Medical Mutual of Ohio – list A4560 as investigational or non-covered.

Modifier KX is required whenever a payer does allow coverage; GA and GY are common on A4560 claims given how often the code is denied as non-covered.

Pabau’s claims management software helps physical therapy, occupational therapy, and rehabilitation practices track DME billing, flag frequently non-covered codes like A4560 before submission, and reduce preventable denials.

HCPCS code A4560 covers replacing a disposable neuromuscular electrical stimulator (NMES) device – not the ongoing electrodes, lead wires, or conductive gel used with an NMES unit the patient already owns, which is a common assumption among providers running claims management software for NMES billing. A meaningful share of claims are denied outright because disposable devices don’t meet Medicare’s durability requirement for DME.

This guide covers the 2026 fee schedule, Medicare and commercial payer coverage positions (including non-coverage and investigational determinations), required documentation, modifiers, crosswalk codes, and the most common denial reasons – with practical steps to avoid each one.

HCPCS code A4560: definition and code details

HCPCS code A4560 is the Healthcare Common Procedure Coding System Level II code for a disposable neuromuscular electrical stimulator (NMES), replacement only. It’s billed when a disposable NMES stimulator device needs to be replaced – not for the electrodes, lead wires, conductive gel, or garments used alongside a durable NMES unit, which are billed under a different code (A4595 – see the crosswalk section below).

The code is maintained by CMS, effective April 1, 2023, and falls within the A-code range covering medical and surgical supplies. In practice, it’s associated with single-use, wearable NMES stimulators such as the geko™ T-3 and geko™ W-3 devices.

What A4560 actually covers: A4560 is billed when a disposable NMES stimulator device needs replacing – not for the electrodes, lead wires, conductive gel, or garments used with it. Those ongoing consumables are billed under A4595 (electrical stimulator supplies, 2-lead, per month – see the crosswalk section below), and the durable device itself is billed under E0745.

Devices billed under A4560 are typically single-use, wearable stimulators such as the geko™ T-3 and geko™ W-3, used short-term for conditions like edema or venous thromboembolism (VTE) prophylaxis rather than the multi-week muscle re-education programs associated with durable NMES units. Providers billing for physical therapy and rehabilitation practices should confirm whether they’re replacing the disposable stimulator itself (A4560) or its ongoing supplies (A4595) before submitting a claim.

2026 Medicare fee schedule for A4560

Medicare reimbursement for A4560, where a rate applies, is set through the CMS Physician Fee Schedule lookup tool and the DME fee schedule. Rates vary by geographic region because CMS applies locality-based adjustments.

Because many DME MACs and commercial payers classify disposable NMES stimulators as not meeting the regulatory definition of durable medical equipment, or as investigational, confirm coverage before assuming a fee schedule rate applies at all (see payer-specific coverage below). The figures below reflect general 2026 Medicare national payment allowance ranges where coverage exists; confirm your specific region’s rate and coverage status directly from the CMS fee schedule files before billing.

Use the AAPC HCPCS code lookup to cross-reference A4560 descriptions and verify that the specific supply being billed falls within the replacement-only designation before submitting a claim.

Medicare coverage criteria for HCPCS A4560

Coverage for A4560 differs sharply from most DME supply codes. Many DME MACs and commercial payers treat disposable NMES stimulators as not meeting the regulatory definition of durable medical equipment – equipment must be able to withstand repeated use with an expected lifespan of at least three years, and a single-use device like those billed under A4560 (for example, the geko™ T-3 and geko™ W-3) doesn’t meet that bar.

As a result, a meaningful share of A4560 claims are denied outright rather than assessed against clinical criteria. Providers billing for occupational therapy and rehabilitation services should check the applicable DME MAC’s coverage determination for A4560 specifically – and the payer-specific policies further down this page – before assuming standard NMES coverage rules apply.

Where a payer does allow coverage, the core criteria typically required are:

• The patient has a documented diagnosis for which a disposable NMES device is clinically indicated
• A valid order or prescription from a treating physician or qualified non-physician practitioner is on file
• The disposable device being replaced was previously supplied under a documented order, and the replacement is not a duplicate within the payer’s allowed frequency
• The replacement falls within the payer’s allowed frequency limits for device replacement
• Medical necessity is clearly documented in the patient’s clinical record, not just referenced in the order
• The supplier is enrolled as a Medicare DME supplier and meets DMEPOS accreditation requirements, for the rare payer that treats the item as a covered DME benefit

NMES is distinct from transcutaneous electrical nerve stimulation (TENS). TENS targets pain management through sensory nerve stimulation, while NMES targets muscle contraction for rehabilitation. Many payers apply different LCDs to each, so confirm which technology the patient is using before selecting A4560 versus TENS-specific supply codes.

Because coverage for A4560 is inconsistent, always confirm with the specific payer whether the code is covered, non-covered, or investigational before dispensing a replacement device – see payer-specific coverage policies below.

Documentation requirements for billing A4560

Inadequate documentation is the most common reason A4560 claims fail on post-payment audit. Maintaining thorough medical forms at your practice for DME supply billing reduces audit exposure. The documentation package for each A4560 claim should include the following.

• Written order: A signed prescription or order specifying NMES therapy, the device type, and the supplies required. The order date must precede the date of service.
• Medical necessity statement: Clinical notes or a letter of medical necessity from the treating provider explaining why NMES therapy and a disposable device replacement are required for this patient’s condition.
• Diagnosis documentation: ICD-10-CM diagnosis codes supporting the medical necessity of NMES use, documented in the patient’s chart and consistent with the claim.
• Proof of prior device and replacement need: Evidence that the patient was previously supplied a disposable NMES device under a valid order, plus documentation of why a replacement is now needed (e.g. device failure, end of single-use lifespan, or loss).
• Replacement frequency log: Records showing when previous supplies were dispensed, supporting that the replacement request falls within payer-approved frequency limits.
• Payer-specific forms: Some DME MACs and commercial payers require additional attestation forms or coverage checklists – verify with the specific payer.

Good HIPAA compliance for medical offices also requires that all DME documentation is retained for at least seven years and is accessible for audit on request.

Prior authorization requirements

Medicare generally does not process prior authorization requests for A4560 at all, because many DME MACs deny disposable NMES stimulators as non-covered before a clinical review ever happens; where a DME MAC does allow coverage, the treating provider must still attest that all criteria are met (via the KX modifier – see below).

State Medicaid programs apply their own rules. Texas Medicaid, administered by the Texas Medicaid and Healthcare Partnership (TMHP), requires prior authorization for NMES-related items including those billed under A4560. Providers billing Texas Medicaid must submit a prior authorization request through the TMHP portal before dispensing the device.

Commercial payers vary, and several – including Medical Mutual of Ohio – list A4560 as investigational rather than payable at all: verify the payer’s coverage stance, not just its prior-authorization rule, before billing, as requirements change at plan renewal. Maintaining physiotherapy practice compliance requirements in a centralized record-keeping system simplifies the coverage and prior-auth tracking process across multiple payers.

How to bill HCPCS code A4560

A4560 claims are submitted on the CMS-1500 claim form (or its electronic equivalent, the 837P transaction) by DME suppliers. Unlike physician service codes, DME supply codes are processed through the DME MAC for the supplier’s jurisdiction, not the local Medicare Administrative Contractor. Consistent use of practice management software with built-in DME billing workflows reduces the risk of claim-form errors.

Key billing steps:

1. Verify the patient’s DME benefit eligibility and coverage for A4560 before dispensing supplies.
2. Confirm the patient meets the applicable LCD’s medical necessity criteria and that documentation is complete.
3. Determine whether prior authorization is required by the specific payer.
4. Select the correct modifier(s) and enter them in Box 24D of CMS-1500.
5. Enter the applicable ICD-10-CM diagnosis code(s) in Box 21 and link them to the A4560 line item in Box 24E.
6. Submit the claim to the DME MAC for the supplier’s jurisdiction (not the patient’s local MAC).

Modifiers used with A4560

Modifier selection directly affects whether Medicare processes a claim or returns it as unprocessable. The table below covers the modifiers most frequently applied to A4560 claims. Use digital intake forms to capture modifier-relevant clinical information at the point of care, reducing downstream billing corrections.

Never append both KX and GY to the same A4560 claim line. KX attests that coverage criteria are met; GY declares the item non-covered. They are mutually exclusive.

Streamline your DME supply billing

Pabau's claims management tools help physical therapy, occupational therapy, and rehabilitation practices track HCPCS supply codes, document medical necessity, and reduce preventable denials. See how Pabau supports compliant DME billing workflows.

Book a demo

Related HCPCS codes and A4560 crosswalk

A4560 sits within a cluster of NMES and TENS-related codes. CMS and payer materials often group A4560 with functional-stimulator device codes – E0731, E0744, E0745, E0764, and E0770 – as a disposable-stimulator replacement item, not a consumable-supply code. Using the wrong code for the specific device or supply being billed is a common source of claim rejection.

The PGM Billing HCPCS lookup tool provides free code search using current CMS data and is useful for confirming descriptions and related codes. The table below maps A4560 to its most relevant crosswalk codes and explains when each applies.

The NMES/TENS distinction is clinically and administratively important. NMES devices produce stronger currents intended to cause muscle contraction; TENS devices use lower-amplitude currents for pain relief. Billing an NMES device code when the patient’s device is actually a TENS unit is a coding error that will result in denial or, if paid, creates overpayment liability.

Just as important: A4560 is for replacing the disposable stimulator device itself, not the ongoing electrodes, lead wires, or gel used with it – those belong under A4595. Confirm both the device type and whether it’s disposable or durable in the patient’s clinical record before selecting a code. NMES therapy sometimes intersects with professional service claims billed under CPT code 97014.

Payer-specific coverage policies for A4560

Coverage for HCPCS code A4560 is not uniform across payers, and unlike most DME supply codes, a meaningful share of payers deny it outright because a disposable device doesn’t meet the regulatory definition of durable medical equipment. Many Medicare DME MACs take this position, and several commercial payers – including Medical Mutual of Ohio – list A4560 as investigational or non-covered in their medical policies.

State Medicaid programs and other commercial payers apply their own criteria. Tracking payer-specific rules in a centralized compliance management software system reduces the risk of billing under the wrong policy. The table below summarizes how major payer types approach A4560.

Always verify the patient’s specific plan benefits before billing A4560 – given how often this code is treated as non-covered or investigational, checking first prevents a guaranteed denial. Even within the same insurer brand, plan-level differences can change coverage status, frequency limits, and modifier requirements. Use the NLM HCPCS Level II API for programmatic code lookups when integrating payer verification into practice management workflows.

Common denials for A4560 and how to avoid them

Denial prevention is where A4560 billing most often breaks down – and for this code, the biggest single driver isn’t a documentation gap, it’s billing a code that a payer has already classified as non-covered. Tracking denial reason codes through your patient care management workflows gives you the data to catch recurring patterns before they compound into significant revenue loss.

• Billed as if routinely covered: Many DME MACs and commercial payers – including Medical Mutual of Ohio – classify disposable NMES stimulators as non-covered or investigational by policy, so claims submitted without first checking the payer’s coverage stance are denied regardless of documentation quality. Fix: check the specific payer’s medical policy for A4560 before dispensing the device, and use GA or GY modifiers (with an Advance Beneficiary Notice) when coverage is unlikely.
• Missing KX modifier: On the rare claim where a payer does cover A4560, Medicare’s claims processing system auto-denies it without KX, because KX is the supplier’s attestation that LCD criteria are met. Fix: build a billing rule that flags any covered A4560 claim submitted without KX and holds it for manual review before submission.
• Insufficient medical necessity documentation: Post-payment audits frequently cite documentation that references NMES therapy without clearly linking the patient’s diagnosis to the clinical need for a disposable device replacement. Fix: use a standardized medical necessity template that explicitly maps the patient’s ICD-10 diagnosis to the functional benefit of NMES, updated at each replacement.
• Wrong code for device type: Billing A4560 for supplies used with a TENS unit rather than an NMES unit. These are not interchangeable codes; payers cross-reference the device type against prior claims history. Fix: confirm device type in the patient record at every replacement supply order.
• Frequency limit exceeded: Submitting for device replacements more frequently than the payer’s allowed replenishment schedule. Fix: track each patient’s device replacement history in your billing system and set alerts when a new replacement order falls within the non-covered frequency window.
• No documentation of prior device and replacement need: A claim for a disposable device replacement cannot be substantiated without records showing the patient was previously supplied the device under a valid order, and why a new one is now needed. Fix: document device replacement history and the clinical reason for replacement at each billing episode.
• Expired or missing prescription: Orders are typically valid for a defined period (often 12 months); billing beyond the order’s validity period results in denial. Fix: track order expiration dates and request renewal in advance of the deadline.

Conclusion

HCPCS code A4560 is easy to misread – the two words that matter most, disposable and replacement, define exactly what it covers and, just as importantly, what it doesn’t. It’s for replacing a disposable NMES stimulator device itself, not the ongoing electrodes, lead wires, or gel that belong under A4595, and a meaningful share of claims are denied outright because disposable devices don’t meet the durability requirement for DME.

Most A4560 denial patterns are predictable: billing it as if routinely covered, missing KX on the rare claim a payer does pay, insufficient documentation of the prior device and replacement need, wrong device type, and expired orders. Each one is preventable by confirming the payer’s coverage stance first, then getting the code, modifiers, and documentation right before the claim goes out.

For physical therapy, occupational therapy, and rehabilitation practices billing DME supply codes, Pabau’s medical practice management software supports the documentation, claims tracking, and compliance workflows that keep A4560 billing accurate and audit-ready. To see how Pabau handles DME billing documentation for your practice, book a demo.

Continue your research

Billing other single-use DME supply codes? HCPCS code E0482 covers a cough stimulating device that follows a similarly strict payer coverage pattern to A4560.

Treating patients with compression therapy for edema? HCPCS code E0667 covers segmental pneumatic appliance billing for full-leg devices.

Also billing PAP interface supplies? HCPCS code A7031 explains the billing rules for full face mask interface replacements.

Managing heated tubing replacements for PAP devices? HCPCS code A4604 covers the billing and coverage rules for that supply code.

Frequently asked questions